Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electromagnetic Radiation Stimulated Learning in Perovskite Nickelates.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Dynamical modeling of individual sensory reactivity and habituation learning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

<i>KCNV2</i>-Deficient Retinal Organoid Model of Cone Dystrophy-In Vitro Screening for AAV Gene Replacement Therapy.

International journal of molecular sciences·2026
Same author

Cautery disbudding in calves: A comparative assessment of topical wound treatments.

Open veterinary journal·2025
Same author

Applied Astrobiology: An Integrated Approach to the Future of Life in Space.

Astrobiology·2025

Related Experiment Video

Updated: Apr 23, 2026

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells
10:48

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells

Published on: October 30, 2017

15.6K

Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells.

Amelia Lane1, Lissa Rachel Philip2, Ludmila Ruban2

  • 1Institute of Ophthalmology and Advanced Centre for Biochemical Engineering, University College London, London, United Kingdom amelia.lane@ucl.ac.uk.

Stem Cells Translational Medicine
|October 3, 2014
PubMed
Summary

Variability in human embryonic stem cell differentiation impacts retinal pigment epithelium cell production for blindness treatments. Tailoring protocols to specific cell lines is crucial for consistent, large-scale cell therapy manufacturing.

Keywords:
Bioprocess engineeringCell differentiationCell therapyHuman embryonic stem cellsRetinal pigment epithelium

More Related Videos

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

8.7K
Deriving Retinal Pigment Epithelium RPE from Induced Pluripotent Stem iPS Cells by Different Sizes of Embryoid Bodies
09:18

Deriving Retinal Pigment Epithelium RPE from Induced Pluripotent Stem iPS Cells by Different Sizes of Embryoid Bodies

Published on: February 4, 2015

9.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells
10:48

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells

Published on: October 30, 2017

15.6K
Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

8.7K
Deriving Retinal Pigment Epithelium RPE from Induced Pluripotent Stem iPS Cells by Different Sizes of Embryoid Bodies
09:18

Deriving Retinal Pigment Epithelium RPE from Induced Pluripotent Stem iPS Cells by Different Sizes of Embryoid Bodies

Published on: February 4, 2015

9.9K

Area of Science:

  • Stem cell biology
  • Ophthalmology
  • Regenerative medicine

Background:

  • Human embryonic stem cells (hESCs) offer potential for treating blindness by differentiating into retinal pigment epithelium (RPE) cells.
  • Current hESC differentiation into RPE cells is inconsistent, hindering large-scale therapeutic applications for conditions like age-related macular degeneration.

Purpose of the Study:

  • To identify and quantify sources of variability in hESC-RPE differentiation.
  • To develop methods for reducing variability and improving RPE cell yield for cell therapy.

Main Methods:

  • Monitoring pigmented cell emergence over time to analyze effects of cell line, passaging, and seeding density.
  • Implementing feeder-free, density-controlled conditions with single-cell dissociation and seeding.
  • Testing small molecule efficacy (dorsomorphin) on RPE differentiation in different hESC lines.

Main Results:

  • Cell line, passaging method, passage number, and seeding density significantly impact RPE yield.
  • Feeder-free, density-controlled conditions with single-cell seeding improve scalability.
  • Dorsomorphin's effect on RPE differentiation varied by cell line, enhancing it in one and reducing it in another.

Conclusions:

  • hESC-RPE differentiation variability can be quantified and mitigated through optimized culture conditions.
  • Tailoring differentiation protocols to individual hESC line characteristics is essential for reproducible RPE production.
  • Standardized protocols are necessary for the clinical translation of hESC-derived RPE cell therapies.